Covid-fighting combo from S.F. biotech, pharma giants reports positive results in mid-stage trial

Last week, GSK and Vir filed for an an emergency use authorization for use of VIR-7831 to treat adolescents and adults with mild to moderate Covid-19 at risk for progression to hospitalization or death.